
Pfizer Inc. plans to ask the U.S. Food and Drug Administration as soon as Tuesday to authorize its COVID vaccine for emergency use in children aged 6 months to 4 years old. If approved, the two-shot regimen would become the first approved for use in children this young; older children are already eligible for the… read on > read on >